Suprachiasmatic nucleus function and circadian entrainment are modulated by G protein-coupled inwardly rectifying (GIRK) channels

Journal of Physiology

Volumn 592, Issue 22, 2014, Pages 5079-5092

  Hablitz, L M ^a   Molzof, H E ^a   Paul, J R ^a   Johnson, R L ^a   Gamble, K L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL 2; NEUROPEPTIDE Y; PER2 PROTEIN; UNCLASSIFIED DRUG; CIRCADIAN RHYTHM SIGNALING PROTEIN; KCNJ6 PROTEIN, MOUSE; PER2 PROTEIN, MOUSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CHRONOBIOLOGY; CIRCADIAN ENTRAINMENT; CIRCADIAN RHYTHM; CONTROLLED STUDY; KNOCKOUT MOUSE; LIGHT DARK CYCLE; MALE; MEMBRANE STEADY POTENTIAL; MOLECULAR CLOCK; MOUSE; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; PER2 GENE; PHOTOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RUNNING; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; MEMBRANE POTENTIAL; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; NEURONS; NEUROPEPTIDE Y; PERIOD CIRCADIAN PROTEINS; SUPRACHIASMATIC NUCLEUS;

EID: 84925379694     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.282079     Document Type: Article

References (73)

1. Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K & van den Pol AN (2005). Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci 25, 7406-7419.
2. Aguado C, Colon J, Ciruela F, Schlaudraff F, Cabanero MJ, Perry C,Watanabe M, Liss B,Wickman K & Lujan R (2008). Cell type-specific subunit composition of G protein-gated potassium channels in. J Neurochem105, 497-511.
3. Albrecht U (2012). Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 74, 246-260.
4. + signaling in dopamine neurons of the ventral tegmental area. J Neurosci 31, 12251-12257.
5. Aton SJ, Huettner JE, Straume M & Herzog ED (2006). GABA and Gi/o differentially control circadian rhythms and synchrony in clock neurons. Proc Natl Acad Sci U S A 103, 19188-19193.
6. Belle MD, Hughes AT, Bechtold DA, Cunningham P, Pierucci M, Burdakov D & Piggins HD (2014). Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock. J Neurosci 34, 3607-3621.
7. Besing RC, Hablitz LM, Paul JR, Johnson RL, Prosser RA & Gamble KL (2012). Neuropeptide Y-induced phase shifts of PER2::LUC rhythms are mediated by long-term suppression of neuronal excitability in a phase-specific manner. Chronobiol Int 29, 91-102.
8. Biello SM (2009). Circadian clock resetting in the mouse changes with age. Age (Dordr) 31, 293-303.
9. Biello SM, Golombek DA, Schak KM & Harrington ME (1997). Circadian phase shifts to neuropeptide Y in vitro: cellular communication and signal transduction. J Neurosci 17, 8468-8475.
10. Blednov YA, Stoffel M, Chang SR & Harris RA (2001). GIRK2 deficient mice. Evidence for hyperactivity and reduced anxiety. Physiol Behav 74, 109-117.
11. 2+ axis controls circuit-level encoding of circadian time in the suprachiasmatic nucleus. Neuron 78, 714-728.
12. BrayMS, RatcliffeWF, GrenettMH, Brewer RA,Gamble KL& Young ME (2013). Quantitative analysis of light-phase restricted feeding reveals metabolic dyssynchrony in mice. Int J Obes (Lond) 37, 843-852.
13. Capucci A, Calcagnini G, Mattei E, Triventi M, Bartolini P, Biancalana G, Gargaro A, Puglisi A & Censi F (2012). Daily distribution of atrial arrhythmic episodes in sick sinus syndrome patients: implications for atrial arrhythmia monitoring. Europace 14, 1117-1124.
14. Cheng HY, Obrietan K, Cain SW, Lee BY, Agostino PV, Joza NA, Harrington ME, Ralph MR & Penninger JM (2004). Dexras1 potentiates photic and suppresses nonphotic responses of the circadian clock. Neuron 43, 715-728.
15. Colwell CS (2011). Linking neural activity and molecular oscillations in the SCN. Nat Rev Neurosci 12, 553-569.
16. Dahdal D, Reeves DC, Ruben M, Akabas MH & Blau J (2010). Drosophila pacemaker neurons require G-protein signaling and GABAergic inputs to generate 24hr behavioral rhythms. Neuron 68, 964-977.
17. Days E, Kaufmann K, Romaine I, Niswender C, Lewis M, Utley T, Du Y, Sliwoski G, Morrison R, Dawson ES, Engers JL, Denton J, Daniels JS, Sulikowski GA, Lindsley CW&Weaver CD (2010). Discovery and characterization of a selective activator of the g-protein activated inward-rectifying potassium (GIRK) channel. In Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information (US), Bethesda, MD, U.S.A.
18. Deboer T & Tobler I (2000). Running wheel size influences circadian rhythm period and its phase shift in mice. J Comp Physiol A 186, 969-973.
19. Doi M, Ishida A, Miyake A, Sato M, Komatsu R, Yamazaki F, Kimura I, Tsuchiya S, Kori H, Seo K, Yamaguchi Y, Matsuo M, Fustin JM, Tanaka R, Santo Y, Yamada H, Takahashi Y, Araki M, Nakao K, Aizawa S, Kobayashi M, Obrietan K, Tsujimoto G & Okamura H (2011). Circadian regulation of intracellular G-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus. Nat Commun 2, 327.
20. Edgar DM, Kilduff TS, Martin CE & DementWC (1991a). Influence of running wheel activity on free-running sleep/wake and drinking circadian rhythms in mice. Physiol Behav 50, 373-378.
21. Edgar DM, Martin CE & DementWC (1991b). Activity feedback to the mammalian circadian pacemaker: influence on observed measures of rhythm period length. J Biol Rhythms 6, 185-199.
22. Fu LY, Acuna-Goycolea C & van den Pol AN (2004). Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24, 8741-8751.
23. Gamble KL, Novak CM & Albers HE (2004). Neuropeptide Y and N-methyl-D-aspartic acid interact within the suprachiasmatic nuclei to alter circadian phase. Neuroscience 126, 559-565.
24. Gamble KL, Paul KN, Karom MC, Tosini G & Albers HE (2006). Paradoxical effects of NPY in the suprachiasmatic nucleus. Eur J Neurosci 23, 2488-2494.
25. Hall AC, Earle-Cruikshanks G & Harrington ME (1999). Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y. Eur J Neurosci 11, 3424- 3432.
26. Hamasaki R, Shirasaki T, Soeda F & Takahama K (2013). Tipepidine activates VTA dopamine neuron via inhibiting dopamine D2 receptor-mediated inward rectifying K+ current. Neuroscience 252, 24-34.
27. HarringtonM, Molyneux P, Soscia S, Prabakar C, McKinley-Brewer J & Lall G (2007). Behavioral and neurochemical sources of variability of circadian period and phase: studies of circadian rhythms of npy-/- mice. Am J Physiol Regul Integr Comp Physiol 292, R1306- R1314.
28. Hastings MH, Duffield GE, Smith EJ, Maywood ES & Ebling FJ (1998). Entrainment of the circadian system of mammals by nonphotic cues. Chronobiol Int 15, 425-445.
29. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I & Kurachi Y (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90, 291-366.
30. Jeyaraj D, Haldar SM,Wan X,McCauley MD, Ripperger JA, Hu K, Lu Y, Eapen BL, Sharma N, Ficker E, Cutler MJ, Gulick J, Sanbe A, Robbins J, Demolombe S, Kondratov RV, Shea SA, Albrecht U,Wehrens XH, Rosenbaum DS & Jain MK (2012). Circadian rhythms govern cardiac repolarization and arrhythmogenesis. Nature 483, 96-99.
31. Jiang ZG, Nelson CS & Allen CN (1995).Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neurons. Brain Res 687, 125-132.
32. Kaufmann K, Romaine I, Days E, Pascual C, Malik A, Yang L, Zou B, Du Y, Sliwoski G, Morrison RD, Denton J, Niswender CM, Daniels JS, Sulikowski GA, Xie XS, Lindsley CW &Weaver CD (2013). ML297 (VU0456810), the First potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem Neurosci 4, 1278-1286.
33. Koyrakh L, Lujan R, Colon J, Karschin C, Kurachi Y, Karschin A &Wickman K (2005). Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J Neurosci 25, 11468-11478.
34. +-channel proteins. Nature 374, 135- 141.
35. Kuhlman SJ & McMahon DG (2004). Rhythmic regulation of membrane potential and potassium current persists in SCN neurons in the absence of environmental input. Eur J Neurosci 20, 1113-1117.
36. Kuhlman SJ & McMahon DG (2006). Encoding the ins and outs of circadian pacemaking. J Biol Rhythms 21, 470- 481.
37. Kuhlman SJ, Silver R, Le Sauter J, Bult-Ito A & McMahon DG (2003). Phase resetting light pulses induce Per1 and persistent spike activity in a subpopulation of biological clock neurons. J Neurosci 23, 1441-1450.
38. Kuroda H, Fukushima M, Nakai M, Katayama T & Murakami N (1997). Daily wheel running activity modifies the period of free-running rhythm in rats via intergeniculate leaflet. Physiol Behav 61, 633-637.
39. Lall GS & Biello SM (2003). Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist. Neuroscience 119, 611-618.
40. + channels. J Biol Chem 270, 28660-28667.
41. Lewandowski MH & Usarek A (2002). Effects of intergeniculate leaflet lesions on circadian rhythms in the mouse. Behav Brain Res 128, 13-17.
42. Loddenkemper T, Vendrame M, Zarowski M, Gregas M, Alexopoulos AV,Wyllie E & Kothare SV (2011). Circadian patterns of pediatric seizures. Neurology 76, 145-153.
43. Lomazzi M, Slesinger PA & Luscher C (2008). Addictive drugs modulate GIRK-channel signaling by regulating RGS proteins. Trends Pharmacol Sci 29, 544-549.
44. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19, 687-695.
45. Luscher C & Slesinger PA (2010). Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11, 301- 315.
46. Maywood ES, Okamura H & Hastings MH (2002). Opposing actions of neuropeptide Y and light on the expression of circadian clock genes in the mouse suprachiasmatic nuclei. Eur J Neurosci 15, 216-220.
47. Mistlberger RE & Skene DJ (2005). Nonphotic entrainment in humans? J Biol Rhythms 20, 339-352.
48. Nelson CS, Marino JL & Allen CN (1996). Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. Neuroreport 7, 717-720.
49. Paredes MF, Greenwood J & Baraban SC (2003). Neuropeptide Y modulates a G protein-coupled inwardly rectifying potassium current in the mouse hippocampus. Neurosci Lett 340, 9-12.
50. Pickard GE (1994). Intergeniculate leaflet ablation alters circadian rhythms in the mouse. Neuroreport 5, 2186-2188.
51. Pickard GE, Ralph MR & Menaker M (1987). The intergeniculate leaflet partially mediates effects of light on circadian rhythms. J Biol Rhythms 2, 35-56.
52. Pizarro A, Hayer K, Lahens NF & Hogenesch JB (2013). CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res 41, D1009-1013.
53. Ruiz de Elvira MC, Persaud R & Coen CW (1992). Use of running wheels regulates the effects of the ovaries on circadian rhythms. Physiol Behav 52, 277-284.
54. Schaap J, Bos NP, de Jeu MT, Geurtsen AM, Meijer JH & Pennartz CM (1999). Neurons of the rat suprachiasmatic nucleus show a circadian rhythm in membrane properties that is lost during prolonged whole-cell recording. Brain Res 815, 154-166.
55. Scott FF, Belle MD, Delagrange P & Piggins HD (2010). Electrophysiological effects of melatonin on mouse Per1 and non-Per1 suprachiasmatic nuclei neurones in vitro. J Neuroendocrinol 22, 1148-1156.
56. Shusterman V,Warman E, London B & Schwartzman D (2012). Nocturnal peak in atrial tachyarrhythmia occurrence as a function of arrhythmia burden. J Cardiovasc Electrophysiol 23, 604-611.
57. + channel GIRK2. Proc Natl Acad Sci U S A 94, 923-927.
58. Soscia SJ & Harrington ME (2004). Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro. Brain Res 1023, 148-153.
59. Soscia SJ & Harrington ME (2005). Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice. Neurosci Lett 373, 175-178.
60. Takigawa M, Kawamura M, Noda T, Yamada Y, Miyamoto K, Okamura H, Satomi K, Aiba T, Kamakura S, Sakaguchi T, Mizusawa Y, Itoh H, HorieM& ShimizuW. (2012). Seasonal and circadian distributions of cardiac events in genotyped patients with congenital long QT syndrome. Circ J 76, 2112-2118.
61. Turek FW, Penev P, Zhang Y, van Reeth O & Zee P (1995). Effects of age on the circadian system. Neurosci Biobehav Rev 19, 53-58.
62. van den Pol AN, Obrietan K, Chen G & Belousov AB (1996). Neuropeptide Y-mediated long-term depression of excitatory activity in suprachiasmatic nucleus neurons. J Neurosci 16, 5883-5895.
63. Vyazovskiy VV, Kopp C,Wigger E, Jones ME, Simpson ER & Tobler I (2006). Sleep and rest regulation in young and old oestrogen-deficient female mice. J Neuroendocrinol 18, 567-576.
64. Wang TA, Yu YV, Govindaiah G, Ye X, Artinian L, Coleman TP, Sweedler JV, Cox CL & Gillette MU (2012). Circadian rhythm of redox state regulates excitability in suprachiasmatic nucleus neurons. Science 337, 839-842.
65. Wang Z (2013). miRNA in the regulation of ion channel/transporter expression. Compr Physiol 3, 599- 653.
66. Welsh DK, Takahashi JS & Kay SA (2010). Suprachiasmatic nucleus: cell autonomy and network properties. Annu Rev Physiol 72, 551-577.
67. Wydeven N, Marron Fernandez de Velasco E, Du Y, Benneyworth MA, Hearing MC, Fischer RA, Thomas MJ, Weaver CD &Wickman K (2014). Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297. Proc Natl Acad Sci U S A 111, 10755-10760.
68. Yannielli PC, Brewer JM & Harrington ME (2004). Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studies. Eur J Neurosci 19, 891-897.
69. Yannielli P & Harrington ME (2004). Let there be 'more' light: enhancement of light actions on the circadian system. Prog Neurobiol 74, 59-76.
70. Yannielli PC & Harrington ME (2000). Neuropeptide Y applied in vitro can block the phase shifts induced by light in vivo. Neuroreport 11, 1587-1591.
71. Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, Siepka SM, Hong HK,OhWJ, YooOJ, MenakerM& Takahashi JS (2004). PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent. Proc Natl Acad Sci U S A 101, 5339-5346.
72. Zarowski M, Loddenkemper T, Vendrame M, Alexopoulos AV, Wyllie E & Kothare SV (2011). Circadian distribution and sleep/wake patterns of generalized seizures in children. Epilepsia 52, 1076-1083.
73. Zuberi Z, Birnbaumer L & Tinker A (2008). The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. Am J Physiol Regul Integr Comp Physiol 295, R1822-R1830.